Non-vascular Stents Market – Minimally Invasive Management of a Wide Variety of Circulatory Disorders
Non-vascular stents are a family of devices used for a variety of applications, including esophageal, biliary, colonic, tracheal, and bronchial implantations. Non-vascular stents employs minimally-invasive procedure for implantation. A minimally-invasive procedure offers faster recovery with reduced pain, and shorter hospital stay. Non-vascular stents are increasingly being used in various applications such as in the treatment of pulmonary, urological, and gastrointestinal diseases. The use of these stents is also increasing in the neural and ophthalmic fields.
Download PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1340
The global non-vascular stents market was valued at US$ 934.7 million in 2017 and is expected to witness a robust CAGR of 4.7% over the forecast period (2017 – 2025).
Increasing demand for minimally invasive procedures is expected to boost market growth
Increasing demand for minimally invasive procedures is expected to be a major factor driving the growth of the global non-vascular stents market. Non-vascular stents involve small accurate incisions, resulting in relatively smaller and lesser noticeable scars incurred by conventional surgical procedures that compromise on patient safety. Such a procedure is associated with faster recovery time, thus reducing a patient’s hospital stay. Furthermore, reduced hospital stay in turn, is expected to lower the risk of contracting hospital-acquired infections such as bloodstream infection, urinary tract infection, etc. among patients. These factors pose as major drivers boosting growth of the non-vascular stents market.
Major factor driving growth of the non-vascular stents market is increasing application of stents in gastrointestinal and glaucoma-related disorders. Rising incidence of urological problems, gastrointestinal diseases, glaucoma, and other conditions, are expected to increase the demand for non-vascular stents. For instance, in the U.S., gastrointestinal hemorrhage was the most common condition leading to hospitalization, with around 500,000 discharges recorded in 2012. Growing prevalence of gastrointestinal cancer is expected be a major factor driving growth of the global non-vascular stents market. Increasing respiratory and gastro-urological morbidities is increasing the demand for non-vascular stents, as these stents help maintain vessel patency. Furthermore, growing demand for minimally invasive procedures, which enable faster recovery, cause less pain, and involve shorter hospital stays, is expected to boost growth of the non-vascular stents market in the near future. Over the recent past, the demand for such stents is witnessing increasing in ophthalmic and neural applications. Both application areas—eyes and the brain—are sensitive to implantation of devices. Non-vascular stents, being a minimally invasive and accurate procedure, is rapidly being adopted for these applications. Smaller stents, known as a micro-stents, are being developed for application in areas related to eyes and the brain.
Browse Complete Report For More Information @ https://www.coherentmarketinsights.com/market-insight/non-vascular-stents-market-1340
Major players operating in the global non-vascular stents market include Allium Medical, Boston Scientific, C.R. Bard, ELLA-CS, S.R.O, EndoChoice, Merit Endotek, Taewoong Medical, and Xlumena.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154